Navigation Links
The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine
Date:6/11/2008

. "This is an immunogenic vaccine without the need for an adjuvant to boost the immune response."

About CELVAPAN

CELVAPAN is manufactured in a cell culture-based system in Bohumil, Czech Republic, at one of the largest cell culture vaccine production facilities in the world. Vero cell technology uses a well-established cell line originally derived from African green monkey kidneys in 1962. A continuous cell line has been derived from these cells so that an unlimited supply of cells is available without the requirement of generating additional cells from animals.

Baxter's candidate avian flu vaccine is derived from the H5N1 strain A/Vietnam/1203/2004. Its antigen composition and structure are identical to the actual virus circulating in nature without the need to enhance an immune response by including adjuvants, additives that may cause side effects. In this Phase I/II study, CELVAPAN induced an immune response that is similar to the body's defense against a natural virus infection. Earlier this year CELVAPAN was accepted for licensure review by the Committee for Medicinal Products for Human Use within the European Medicines Agency, making it the first cell culture-based pandemic influenza vaccine to be reviewed by the regulatory authority. The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is also conducting a trial with Baxter's CELVAPAN in the United States.

Phase I/II Clinical Trial Results

The randomized Phase I/II study enrolled 284 subjects in Austria and Singapore (ages 18-45) and met its immunogenicity and safety endpoints. The study mainly investigated the ability of the vaccine to induce substantial levels of cross-immunity against divergent H5N1 strains.

The trial tested four different antigen concentrations ranging from 3.75 micrograms to 30 micrograms; 7.5 micrograms and 15 micrograms formulations were studied with and without adjuvant (additive).
'/>"/>

SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
2. Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds
3. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
4. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
5. New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
6. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
7. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
8. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
9. Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion
10. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
11. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 30, 2015 Takeda Pharmaceutical Company Limited ... fulfill the post-marketing commitment and submissions of data ... Multi-Database Bladder Cancer Risk Characterization Study , a ... conducted in four European countries, for pioglitazone containing ... 10 years of follow-up. Findings demonstrate that there ...
(Date:7/30/2015)... SAN FRANCISCO , July 30, 2015 ... devices market is expected to reach USD 23.01 ... Grand View Research, Inc. Growing base of geriatric population, ... and infections, and rising level of awareness among target ... impact rendering drivers over the forecast period. According to ...
(Date:7/30/2015)... What can be expected from ... going to grow at the fastest rates? Visiongain ... 2025, assessing data, trends, opportunities and prospects there. ... charts, and graphs. Discover the most lucrative areas in ... study lets you assess forecasted sales at overall world ...
Breaking Medicine Technology:Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 2Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 6ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 2ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 4ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 6
(Date:7/30/2015)... Miami, FL (PRWEB) , ... July 30, 2015 , ... ... Florida, according to the Health News Florida on June 17th. Those untreated ... needle exchange programs to prevent the spread of dirty needles throughout the community. Ultimately ...
(Date:7/30/2015)... ... July 30, 2015 , ... Gummy smile surgeon, ... gum contouring and surgery, as well as the patented gum depigmentation treatmet. Dr. Farnoosh ... him popular with many patients from around the world. , “Like treatment of any ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... Mount Sinai Earns National Cancer Institute Designation , The Tisch Cancer Institute (TCI) ... National Cancer Institute (NCI)-designated cancer center. TCI joins an elite group of 69 ...
(Date:7/30/2015)... ... 30, 2015 , ... Bird B Gone, the leader in bird control products ... to repel pest birds from the AC units and ventilation systems on hospital roofs. ... even the West Nile virus. When these droppings dry, the fine powder can be ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... managers at multinational organizations and NGO’s, according to a new survey by leading ... shows that property damage and employee medical expenses represented the largest sources of ...
Breaking Medicine News(10 mins):Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 3Health News:Gummy Smile Dentist, Alex Farnoosh DMD, is Now Offering Comprehensive Treatment Options for Gummy Smiles 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 3Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 4Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 5Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 6Health News:Bird B Gone’s New Bird Hazing System Keeps Disease-Carrying Bird Droppings Out of Hospitals 2Health News:New Clements Worldwide Global Risk Survey Shows Political Risk and Instability Top Managers' Concerns 2Health News:New Clements Worldwide Global Risk Survey Shows Political Risk and Instability Top Managers' Concerns 3
... localised prostate cancer, one of the more common cancers ... researchers at Sweden's Karolinska Institutet said. ... blood of a group of cancer patients and monitored ... was part of the Scandinavian Prostate Cancer Group collaboration. ...
... recent report has zeroed in on a potential threat to ... the influence of anti-allergy drugs. ,A survey ... that one in seven suffered from hayfever or other allergies ... ,Many of those questioned said they had ...
... smoking ban which began March 2004, has worked on many ... pollution, the health of bar workers has improved considerably. ... percent reduction in air pollution and an 80 percent cut ... published in the American Journal of Respiratory and Critical Care ...
... a Body Mass Index (BMI) of more than 30 than ... more likely, according to research published in the April issue ... figures for more than a thousand children over two decades ... but that levels were much more constant among teenagers included ...
... Safety study triggered decision to go beyond standard ... critical care experts at The Johns Hopkins Hospital ... hospital superbugs for every child admitted to its ... more stringent admission screening methods for methicillin-resistant Staphylococcus ...
... pentoxifylline appears to have limited benefit in the first-line ... according to a report in the April issue of ... a second report in the same issue finds that ... effective in patients with another ulcer-causing mouth disease, oral ...
Cached Medicine News:Health News:Method to Screen Prostate Cancer Less Effective 2Health News:Ireland’s Smoke Ban Seems To Do The Tric 2Health News:20-year Study Shows Significant Rise in Childhood Obesity, Especially Among Girls 2Health News:Johns Hopkins Begins Aggressive Screening for 'superbugs' in Children 2Health News:Johns Hopkins Begins Aggressive Screening for 'superbugs' in Children 3Health News:Clinical Studies Evaluate Potential Treatments for Mouth Ulcers 2Health News:Clinical Studies Evaluate Potential Treatments for Mouth Ulcers 3
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
... breadth of infectious disease ELISA products make ... standard assay protocols for faster integration into ... products provide increased reliability and run-to-run consistency. ... detection assays for a wide range of ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
Medicine Products: